Thrombotic disease in the myeloproliferative neoplasms.
Falanga A, Marchetti M.
Hematology Am Soc Hematol Educ Program. 2012;2012:571-81.
Venous thromboembolism in the hematologic malignancies.
Falanga A, Marchetti M, Russo L.
Curr Opin Oncol. 2012 Nov;24(6):702-10.
Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.
Falanga A, Vignoli A, Diani E, Marchetti M.
Patient Relat Outcome Meas. 2011 Jul;2:175-88
6th International Conference on Thrombosis and Hemostasis Issues in Cancer. Preface.
Falanga A, Brenner B, Rickles FR.
Thromb Res. 2012 Apr;129 Suppl 1:ix.
Microparticles in tumor progression.
Falanga A, Tartari CJ, Marchetti M.
Thromb Res. 2012 Apr;129 Suppl 1:S132-6.
Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.
Marchetti M, Diani E, ten Cate H, Falanga A.
Haematologica. 2012 Aug;97(8):1173-80.
Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies.
Dienava-Verdoold I, Marchetti MR, te Boome LC, Russo L, Falanga A, Koene HR, Mertens K, Brinkman HJ.
Thromb Haemost. 2012 Mar;107(3):468-76.
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.
Mandalà M, Falanga A, Roila F; ESMO Guidelines Working Group.
Ann Oncol. 2011;22 Suppl 6:vi85-92
Epidemiology, risk and outcomes of venous thromboembolism in cancer.
Falanga A, Russo L.
Hamostaseologie. 2012;32(2):115-25.
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1).
Siragusa S, Armani U, Carpenedo M, Falanga A, Fulfaro F, Imberti D, Laurora R, Molinari AC, Prisco D, Silingardi M, Verso M, Visonà A; Italian Society for Haemostasis and Thrombosis.
Thromb Res. 2012;129(5):e171-6.
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Larocca A, Cavallo F, Bringhen S, Di Raimondo F, Falanga A, Evangelista A, Cavalli M, Stanevsky A, Corradini P, Pezzatti S, Patriarca F, Cavo M, Peccatori J, Catalano L, Carella AM, Cafro AM, Siniscalchi A, Crippa C, Petrucci MT, Yehuda DB, Beggiato E, Di Toritto TC, Boccadoro M, Nagler A, Palumbo A.
Blood. 2012 Jan 26;119(4):933-9; quiz 1093.